Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways

Blood

Volumn 103, Issue 1, 2004, Pages 120-127

  Fukuda, Seiji ^b   Mantel, Charlie R ^b   Pelus, Louis M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN P21; STEM CELL FACTOR; SURVIVIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMING UNIT M; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE LOSS; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; REGULATORY MECHANISM; WILD TYPE;

EID: 0346336791     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1756     Document Type: Article

References (62)

1. Li F, Ackermann EJ, Bennett CF, et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol. 1999;1:461-466.
2. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-921.
3. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhlsa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA. 1999;96:1457-1462.
4. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584.
5. Suzuki A, Shiraki K. Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival. Histol Histopathol. 2001;16:583-593.
6. Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene. 2000;19:1346-1353.
7. Conway EM, Pollefeyt S, Cornelissen J, et al. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood. 2000;95:1435-1442.
8. Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 2000;60:2805-2809.
9. Grossman D, Kim PJ, Schechner JS, Altieri DC. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A. 2001;98:635-640.
10. Mesri M, Wall NR, Li J, Kim RW, Altieri DC, Cancer gene therapy using a survivin mutant adeno-virus. J Clin Invest. 2001;108:981-990.
11. Kanwar JR, Shen W-P, Kanwar RK, Berg RW, Krissansen GW. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst. 2001;93:1541-1552.
12. Fortugno P, Wall NR, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci. 2002;115:575-585.
13. Jiang X, Wilford C, Duensing S, Munger K, Jones G, Jones D. Participation of survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem. 2001;83:342-354.
14. Kallio MJ, Nieminen M, Eriksson JE. Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J. 2001;15:2721-2723.
15. Giodini A, Kallio MJ, Wall NR, et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002;62:2462-2467.
16. Skoufias DA, Mollinari C, Lacroix FB, Margolis RL. Human survivin is a kinetochore-associated passenger protein. J Cell Biol. 2000;151:1575-1582.
17. + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 2001;98:2091-2100.
18. - cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood. 2002;100:2463-2471.
19. + hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle. 2002;1:322-326.
20. Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene. 2000;19:3225-3234.
21. Ito T, Shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 2000;31:1080-1085.
22. Hikita S, Hatano M, Inoue A, et al. Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation. Mol Immunol. 2002;39:289-298.
23. Blagosklonny MV. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle. 2002;1:391-393.
24. el-Diery WS, Tokino T, Velculesco VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
25. Harper JW, Adami GR, Wei N, Keyomarsi K. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G 1 cyclin-dependent kinases. Cell. 1993;75:805-816.
26. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82:675-684.
27. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Therapeut. 2002;1:639-649.
28. cip-1 wa-1 deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood. 1999;93:390-1398.
29. Gartel AL, Tyner AL. Transcriptional regulation of the p21(WAF1/CIP1) gene. Exp Cell Res. 1999;246:280-289.
30. LaBaer J, Garrett MD, Stevenson LF, et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997;11:847-862.
31. Glaser T, Wagenknecht B, Weller M. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene. 2001;20:3936-3947
32. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1612.
33. cipi/wat1. Science. 2000;287:1804-1808.
34. cip-1 in the maintenance of stem/progenitor cells in vivo. Blood. 1996;88:3710-3719.
35. Braun SE, Mantel C, Rosenthal M, et al. A positive effect of p21 cip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer. Blood Cells Mol Dis. 1998;24:138-148.
36. cip1/waf1 associated with steel factor synergy in MO7e. Biochem Biophys Res Commun. 2001;280:675-683.
37. Wat1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 1999;18:1131-1138.
38. Roninson IB. Oncogenic functions of tumour suppressor p21 (Wafl/Cipl/Sdil): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002;179:1-14.
39. Gorospe M, Crielli C, Wang X, Seth P, Capogrossi MC, Hulbrook NJ. p21 (Wafl/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 1997;14:929-935.
40. Mahyar-Roemer M, Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene. 2001;20:3387-3398.
41. Ozaki K, Hanazawa S. Porphyromonas gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via extracellular signal-regulated kinase-dependent expression of p21 Cip/WAF1. Infect Immun. 2001;69:4944-4950.
42. Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21Cip1/WAF1 enhances protein stability of p21Cip1/WAF1 and promotes cell survival. J Biol Chem. 2002;277:11352-11361.
43. Cip1/WAF1 by Akt-induced phosphorylatio in HER-2/neu-over-expressing cells. Nat Cell Biol. 2001;3:245-252.
44. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade. Mol Cell, 1998;1:553-563.
45. cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A. 2000;97:13103-13107.
46. Wognum AW, Visser TP, Peters K, Bierhuizen MF, Wagemaker G. Stimulation of mouse bone marrow cells with kit ligand, FLT3 ligand, and thrombopoietin leads to efficient retrovirus-mediated gene transfer to stem cells, whereas interleukin 3 and interleukin 11 reduce transduction of short-and long-term repopulating cells. Hum Gene Ther. 2000;11:2129-2141.
47. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med. 1991;174:63-71.
48. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991;65:1143-1152.
49. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000;2:65-67.
50. Sawyer ST, Jacobs-Helber SM. Unraveling distinct intracellular signals that promote survival and proliferation: study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells. J Hematother Stem Cell Res. 2000;9:21-29.
51. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem. 2002;277:3247-3257.
52. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Mol Cell Biol. 2001;2:21-32.
53. Smits VAJ, Medema RH. Checking out the G2/M transition. Biochim Biophys Acta. 2001;1519:1-12.
54. Castedo M, Perfettini J-L, Roumier T, Kroemer G. Cyclin-dependent kinase-1: Linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 2002;9:1287-1293.
55. 1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res. 1999;59:3831-3837.
56. Cdc2 kinase. Mol Cell. 1998;2:581-591.
57. Meikrantz W, Schlegel R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem. 1996;271:10205-10209.
58. Medema RH, Klompmaker R, Smits VA, Rijksen G. p21waf1 can block cells at two points in the cell cycle, but does not interfere with progressive DNA-replication or stress-activated kinases. Oncogene. 1998;16:431-441.
59. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS, Senderowicz AM. Perifosine, a novel alky-Iphospholipid, induces p21 (WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Cancer Res. 2002;62:1401-1409.
60. Mantel CR, Gelfanov VM, Kim Y-J, Lee Y, Boswell HS, Broxmeyer HE. P21waf1-Chk1 pathway monitors G1-phase microtubule integrity and id crucial for restriction point transition. Cell Cycle. 2002;1:327-336.
61. Nakanishi M, Adami GR, Robetorye RS, et al. Exit from GO and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci USA U S A. 1995;92:4352-4356.
62. Lör K, Möitz C, Contente A, Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem. 2003;278:32507-32516.